Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115160) titled 'Application of OROS(R) Hydromorphone in cancer pain patients with poor analgesic effect of oxycodone hydrochloride sustained-release tablets' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Condition:
Cancer pain
Intervention:
Morphine ER Group:Equivalent rotation of oxycodone with Morphine Sulfate Extended-release Tablets
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Morphine ER Group:68;Hydromorphone group:68;
Countries o...